The antipyretic drugs for children global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Antipyretic Drugs For Children Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The antipyretic drugs for children market size has grown strongly in recent years. It will grow from $3.02 billion in 2023 to $3.21 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing awareness of pediatric health leading to higher demand for antipyretic medications, growing incidence of fever-related illnesses in children worldwide, rising healthcare expenditures among families to treat common childhood fevers, increasing access to over-the-counter antipyretic drugs in emerging markets and growing emphasis on preventive healthcare and early treatment of pediatric fevers.
The antipyretic drugs for children market size is expected to see strong growth in the next few years. It will grow to $4.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising focus on pediatric healthcare advancements boosting the demand for safer antipyretic drugs, growing prevalence of viral infections in children fueling the need for antipyretic treatments, increasing government initiatives to improve pediatric healthcare access in developing countries, advances in drug formulations and delivery mechanisms enhancing the efficacy of antipyretics and expansion of pharmaceutical companies in emerging markets driving the availability of pediatric medications. Major trends in the forecast period include technological innovations in pediatric drug formulations for faster and safer fever relief, shift towards natural and herbal-based antipyretic drugs for children, increasing focus on personalized pediatric treatments for managing fevers, growing adoption of telemedicine platforms to access pediatric consultations for fever management and development of combination antipyretic drugs targeting multiple symptoms in children.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/antipyretic-drugs-for-children-global-market-report
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
A growing number of viral and bacterial infections is expected to propel the growth of the antipyretic drugs for children market going forward. Viral infections are caused by viruses, which invade and replicate inside host cells, leading to diseases such as flu (influenza). Bacterial infections result from harmful bacteria entering the body and multiplying, causing illnesses such as strep throat or tuberculosis. The incidence of viral and bacterial infections is increasing due to factors such as growing antibiotic resistance, global travel, and population density, which facilitate the spread of pathogens. Antipyretic drugs, such as acetaminophen or ibuprofen, are used in children to reduce fever and alleviate discomfort caused by viral or bacterial infections. For instance, in May 2022, according to The Office for National Statistics, a UK-based non-ministerial department, between December 2021 and March 2022, there were 6,898 deaths due to flu and pneumonia in the UK, an increase from the 5,288 deaths recorded during the same period in 2020-2021. This reflects a rise of over 1,600 deaths year-over-year. Therefore, the growing number of viral and bacterial infections is driving the growth of the antipyretic drugs for children market.
Market Trends –
Major companies operating in the antipyretic drugs for children market are focused on developing advanced drug formulations, such as medicine gummy bites, to enhance ease of administration and improve compliance among young patients. Medicine gummy bites are chewable, gummy-form medications designed to make taking medicine more appealing, especially for children. They come in various forms and flavors to help improve compliance and make the process easier. For instance, in October 2023, DrKids, a US-based pharmaceutical company, launched an acetaminophen gummy bite. It is an innovative medicine offering a child-friendly pain and fever relief alternative. It features an exact dosing system that simplifies medicine administration for parents while ensuring safety and effectiveness.
The antipyretic drugs for children market covered in this report is segmented –
1) By Drug Class: Acetaminophen, Ibuprofen, Other Drug Classes
2) By Dosage Form: Tablets, Syrups, Suppositories, Other Dosage Forms
3) By Age Group: Newborns, Infants, Toddlers, Children
Get an inside scoop of the antipyretic drugs for children market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18956&type=smp
Regional Insights –
North America was the largest region in the antipyretic drugs for children market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipyretic drugs for children market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the antipyretic drugs for children market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol Myers Squibb, GlaxoSmithKline plc, Reckitt Benckiser Group, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Towa Pharmaceutical Co Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Limited
Table of Contents
1. Executive Summary
2. Antipyretic Drugs For Children Market Report Structure
3. Antipyretic Drugs For Children Market Trends And Strategies
4. Antipyretic Drugs For Children Market – Macro Economic Scenario
5. Antipyretic Drugs For Children Market Size And Growth
…..
27. Antipyretic Drugs For Children Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
